HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
Future Microbiol (2020) 15:117383
Only a medical professional should use this site, as it is located close to mayor blood vessels and your sciatic nerve, which be damaged if the injection is not administrated properly
pharmacies, third-party tested for purity
The conserved disulfide bridgeanalogous to Cys182Cys189 in full-length hGHpotentially confers structural stability by locking the peptide into a bioactive conformation
IGF-1 LR3 Reconstitution Guide IGF-1 LR3 ships as a freeze-dried powder